Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-03

Clinical Trial Update: A Study to Determine the Effects of TM30339 on Weight Loss in Obese Individuals. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating TM30339 for weight loss in obesity was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TM30339 (TM30339)

Snippet

Sponsor: 7TM Pharma A/S | Conditions: Obesity | Phase 2 | Status: TERMINATED